Jetema Co (216080.KQ) Stock Price

Jetema Co Price

KOSDAQ·CLOSED
5,940.00
​
Market closed

Over the last 8 years Jetema Co grew revenue by 32.3% annually, reaching 76.90 B KRW. Earnings per share have grown at 13.0% per year over the last 2 years. For Jetema Co, the net margin of -8.6% is down versus 32.8% a few years ago. The consensus 12-month price target for Jetema Co is 9,180.00 KRW, about 54.5% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Jetema Co stock price

Access this data via the Eulerpool API

Jetema Co business model & stock analysis

Jetema Co., Ltd. is engaged in the manufacturing and distributing of aesthetic products, including dermal filler, a thread, a botulinum toxin and other medical devices. The company is headquartered in Wonju, Gangwon-Do and currently employs 187 full-time employees. The company went IPO on 2019-11-14. CO,.LTD is a Korea-based company principally engaged in the development and manufacturing of hyaluronic acid fillers used for facial beauty and other medical devices. The firm manufactures and sells medical devices for improvement of wrinkle, contour and volume. In addition, the Company also engages in the manufacturing and sale of laser equipment used for treatment of leukoplakia, psoriasis and alopecia areata, lifting medical device epiticons, cosmetic mask packs, pharmaceutical excaine creams as well as others.

Frequently asked questions about Jetema Co

Analysts currently set an average price target of 9,180.00 KRW for the Jetema Co stock (median: 9,180.00 KRW), implying +54.5 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Jetema Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Jetema Co to generate revenue of 90.00 B KRW and earnings per share of 45.13 KRW.

Converted at the current exchange rate, the Jetema Co share trades at 3.96 EUR (5,940.00 KRW).

The Jetema Co share (216080.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (216080.KQ).

The expected revenue of Jetema Co is 90.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Jetema Co is 1.68 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Jetema Co is currently 131.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jetema Co stock.

The price-to-sales ratio (P/S) of Jetema Co is currently 2.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jetema Co stock.

The Eulerpool Quality Score for Jetema Co is 2/10.

The ISIN of Jetema Co is KR7216080002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Jetema Co is 216080.KQ. The ticker symbol is used to trade Jetema Co shares on the stock exchange.

Fair ValueTerminal
5,049.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
411.25 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website jetema.com
Country
South Korea
Currency
KRW
Initial public offering
Nov 14, 2019
ISIN
KR7216080002
Cusip
Y7S84R107
Market capitalization
212.24 B KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
126.38
P/Ee 2027
38.57
P/S
P/Se
2.46
EV/EBIT
67.41
P/B Ratio
3.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.71 %
Last updated Oct 9, 2026, 12:29 AM

Jetema Co Peer Group

Jetema Co Ticker

KOSDAQ · 216080.KQ

Jetema Co FIGI

216080:KS · BBG00K9LFPR8216080:KQ · BBG00QL54SN6